Concepedia
Statistics
Publications
12
Citations
554
H-Index
Active since
2011
Affiliations
Duke University(Current)
Broad Institute
Dana-Farber Cancer Institute
Ohio Northern University
Harvard University
Nathaniel W. Mabe is an author at Duke University specializing in oncology, molecular biology, and medicine.
Publications per year
2011–2024
Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1
Nathaniel W. Mabe, Min Huang, Guillermo Nicolás Dalton et al. · Nature Cancer · 2022 · 110 citations · Full text
Medicine, Neuroscience, Oncology +12
Regulator of G Protein Signaling 6 Protects the Heart from Ischemic Injury
Boyd R. Rorabaugh, Bandana Chakravarti, Nathaniel W. Mabe et al. · Journal of Pharmacology and Experimental Therapeutics · 2016 · 61 citations · Full text
Life Sciences, Cardiology, Molecular Biology +11
RIPK3 upregulation confers robust proliferation and collateral cystine-dependence on breast cancer recurrence
Chao‐Chieh Lin, Nathaniel W. Mabe, Yi-Tzu Lin et al. · Cell Death and Differentiation · 2020 · 57 citations · Full text
Medicine, Cancer Biology, Oncology +13
VRK1 as a synthetic lethal target in VRK2 promoter–methylated cancers of the nervous system
Jonathan So, Nathaniel W. Mabe, Bernhard Englinger et al. · JCI Insight · 2022 · 57 citations · Full text
Life Sciences, Molecular Biology, Oncology +16
Epigenetic silencing of tumor suppressor Par-4 promotes chemoresistance in recurrent breast cancer
Nathaniel W. Mabe, Douglas B. Fox, Ryan Lupo et al. · Journal of Clinical Investigation · 2018 · 53 citations · Full text
Medicine, Molecular Biology, Oncology +17
1–5 of 12